Yüklüyor......
Refractory Sjögren's syndrome myelopathy successfully treated with subcutaneous tocilizumab: A case report
RATIONALE: It is known that 5% to 34% of Sjögren's syndrome (SS) cases are complicated by neuropathy in the form of myelitis. Although SS myelopathy (SSM) is often treated with glucocorticoid (GC) and immunosuppressants such as cyclophosphamide (CY), a therapeutic strategy for SSM has not been...
Kaydedildi:
| Yayımlandı: | Medicine (Baltimore) |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wolters Kluwer Health
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6635267/ https://ncbi.nlm.nih.gov/pubmed/31277158 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MD.0000000000016285 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|